Larotrectinib

Active Ingredient

All Co-Formulated Excipients (0 Total)

None

Available Products (2 Total)

Product name Manufacturer Route Approved Date
1. Vitrakvi Loxo Oncology, Inc. Oral
2. Vitrakvi Bayer Healthcare Pharmaceuticals Inc. Oral

Comments